JQDN

General

Ischemic Heart Disease Drugs Global Market Report 2024

Di: Stella

2024 Heart Disease and Stroke Statistics Update: A Report of US and Global Data From the AHA Writing Group Chair Seth Martin, MD, MHS, FAHA and Vice Chair Latha Palaniappan, MD, MS summarize what’s new and discuss a

Global Ischemic Heart Disease Drugs Market Research Report 2024

Ischemic Heart Disease (IHD) Drugs Global Market Report 2025 – Ischemic heart disease (IHD) drugs refer to medications employed in the management and treatment of a condition characterized by reduced blood flow to the heart muscle, often due to narrowing of the coronary arteries. These drugs aim to alleviate symptoms, reduce the risk of complications Global Ischemic Heart Disease (IHD) Drugs Market was valued at USD 5.98 Billion in 2024 and is expected to reach USD 7.57 Billion by 2030 with a CAGR of 4.20% during the forecast period. 세계의 허혈성 심질환 (IHD) 치료제 시장 보고서 (2025년) Ischemic Heart Disease (IHD) Drugs Global Market Report 2025 발행일: On demand Report | 리서치사: The Business Research Company | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)

Photo | 2024 Stat Update infographic | American Heart Association

The global market for Ischemic Heart Disease (IHD) Drugs was estimated at US$6.1 Billion in 2023 and is projected to reach US$7.2 Billion by 2030, growing at a CAGR of 2.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) — The „Ischemic Heart Disease (IHD) Drugs – Global Strategic Business Report“ report has been added to ResearchAndMarkets.com’s offering. The global market The global market for Ischemic Heart Disease Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during CAGR and the forecast period 2024-2030. The ischemic heart disease drugs market was valued at USD 4.94 Billion in 2024, driven by the rising incidence of heart diseases across the globe. The market is expected to grow at a CAGR of 4.35% during the forecast period of 2025-2034, with the values likely to attain USD 7.56 Billion by 2034. Ischemic Heart Disease Drugs Market Overview

Sizing and Forecast The ischemic heart disease (ihd) drugs market size has grown strongly in recent years. It will grow from $6.02 billion in 2023 to $6.36 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising global prevalence of ischemic heart disease, increased awareness and diagnostics, The global heart disease increased awareness market for Ischemic Heart Disease (IHD) Drugs estimated at US$6.3 Billion in the year 2024, is expected to reach US$7.2 Billion by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. Angina Pectoris, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the

Ischemic Heart Disease Drugs Market Report by Disease Class, Drug Class, and Region 2024-2032 – The global ischemic heart disease (IHD) drugs market size reached US$ 6.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032. The ischemic heart disease drugs market was valued at USD 4.94 Billion in 2024, driven by the rising incidence of heart diseases across the globe. The market is expected to grow at a CAGR of 4.35% during the forecast period of 2025-2034, with the values likely to attain USD 7.56 Billion by 2034. Ischemic Heart Disease Drugs Market Overview The global market for Ischemic Heart Disease (IHD) Drugs estimated at US$6.3 Billion in the year 2024, is expected to reach US$7.2 Billion by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. Angina Pectoris Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$4.3 Billion by the end of the analysis period.

The global burden of IHD will increase further by 2050, potentially due to population ageing and economic disparities. Hence, it is necessary to strengthen the prevention of IHD and formulate targeted strategies according to different SDI regions and special populations. IMARC Group provides an analysis of the key trends in each sub-segment of the global ischemic heart disease (IHD) drugs market report, along with forecasts at the global and regional level from 2023-2028. The Ischemic Heart Disease Drugs Market is driven by the rising burden of cardiovascular disease, innovation in lipid-lowering and anti-thrombotic therapies.

Cardiovascular Drugs Market Size to Worth USD 207.78 billion

The global cardiovascular drugs market was evaluated at USD 144.11 billion in 2023 and is poised to grow from USD 149.99 billion in 2024 to USD 207.78 billion by 2033, growing at a CAGR of 4% from 2024 to 2033. Global Ischemic Heart Disease Drugs Market Size, Share, Growth, Trends, Drivers, 3 over Restraints, COVID-19 Impact Analysis – Industry Forecasts from 2023 to 2030 Ischemic heart disease (IHD) has been the fastest-increasing cause of mortality and disability worldwide. A global burden of disease (GBD) study reports epidemiological measures and composite measures as well as

25 Mar, 2024 The ischemic heart disease (IHD) drugs market size has exhibited strong growth in recent years, climbing from $6.02 billion in 2023 to $6.36 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. This growth in the historic period is attributed to factors such as the rising global prevalence of ischemic heart disease, increased awareness and diagnostics,

Heart Disease and Stroke Statistics - 2024 Update - Professional Heart ...

Israel ischemic heart disease (IHD) Drugs Market is expected to grow at an impressive rate during the forecast period, 2024-2028. The major factors include the rising prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes and the growing adoption of technological of 3 advancement. Coronary Artery Disease (CAD) (Ischemic Heart Disease) market report contains a holistic evaluation of the market including a comprehensive analysis of key segments, trends, drivers, competitive landscape, and factors that are playing a significant role in the market.

Ischemic Heart Disease – IHD Drugs market will be growing at a CAGR of 5.52% during 2025 to 2033. The Global Ischemic Heart Global Ischemic Heart Disease Disease (IHD) Drugs Market, valued at USD 6.3B in 2023, is projected to reach USD 9.1B by 2032, growing at a 4.1% CAGR.

Global Ischemic Heart Disease Drugs Market Growth 2024-2030

The global Ischemic Heart Disease Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. Global Ischemic Heart Disease Drugs Market Size, Share, Trends and industry analysis now available from IndustryARC.Report reveals Ischemic Heart Disease Drugs Market in the industry by Type, Products and application.

The Ischemic Heart Disease (IHD) Drugs Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – The ischemic Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a

Global Ischemic Heart Disease Drugs Market Research Report 2024 According to Mr Accuracy reports’s new survey, global Ischemic Heart Disease Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia

The global ischemic heart disease drugs market is witnessing trends such as the increasing prevalence of cardiovascular diseases and advancements in drug development, including novel therapies and LONDON, March 20, 2024 (GLOBE NEWSWIRE) — As per The Business Research Company’s Ischemic Heart Disease (IHD) Drugs Global Market Report 2024, the ischemic heart disease (IHD) drugs market has demonstrated substantial growth in recent years, with promising projections for the future. From $6.02 billion in 2023, the ischemic heart disease (IHD) drugs

According to our LPI (LP Information) latest study, the global Ischemic Heart Disease Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Ischemic Heart Disease Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. On March 20, 2024, The Business Research Company’s research on the Global Ischemic Heart Disease Drugs Market report gain traction for its detailed coverage and latest market numbers. The global market for Ischemic Heart Disease Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global ischemic heart disease (IHD) drugs market is driven by the growing awareness about their advantages, along with the development of more advanced drugs across the globe. The market is expected to reach USD 9.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032. North America leads the market, accounting for the largest ischemic heart disease

Looking for actionable insights in the Ischemic Heart Disease Drugs Market? Our latest report reveals that the market stood at in 2024 and is expected to climb to by 2033, posting a strong CAGR of

Angiotensin II receptor blockers – for reducing blood pressure Heart Disease Market: According to Forecast Link, the market for major heart disease prescription drug sales contributed $67 billion in 2018 and has only grown at a CAGR of 0.6% since 2014, mainly due to the significant generic erosion of a blockbuster hypertension brand from late 2013.